CXCR4-targeting radiotherapeutics (University of British Columbia)

N/A

Report date: 2025/06/11 11:08:49
NME

Base Information

Drug NameCXCR4-targeting radiotherapeutics (University of British Columbia)
Drug Alias NameBL-01-[177Lu]177Lu-BL-01Lutetium-177-BL-01
ClassificationSmall moleculesRadiation-emitting products > Radioactive therapeutic agent
Mechanisms of ActionC-X-C motif chemokine receptor 4 modulators
TargetsC-X-C motif chemokine receptor 4
Therapy Area/IndicationsLymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsLymphoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A